Inflammatory Myofibroblastic Tumor
📧 Sign up to get email alerts when something new happens for Inflammatory Myofibroblastic Tumor.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-09-07FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2018-12-06FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) submitted by Pfizer Laboratories Div Pfizer Inc.